Brazil vs Cambodia: Previously treated cases tested for RR-/MDR-TB
Brazil
72.0%
in 2024
Cambodia
72.0%
in 2024
Brazil rank
128th
Cambodia rank
128th
Previously treated cases tested for RR-/MDR-TB over time
- Brazil
- Cambodia
How they compare
Brazil currently reports 72.0% against 72.0% in Cambodia, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2007 it was Brazil ahead.
Brazil ranks 128th and Cambodia ranks 128th of 180 countries.
Across the 3 decades both report, Brazil averaged higher in 1 and Cambodia in 2.
Head to head by decade
| Decade | Brazil | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.5% | 3.6% | 2.9% | Brazil |
| 2010s | 17.8% | 42.5% | 24.8% | Cambodia |
| 2020s | 69.0% | 70.5% | 1.5% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Brazil or Cambodia?
- Brazil, at 72.0% against 72.0% in Cambodia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Brazil and Cambodia?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Cambodia?
- 10 years are reported by both, from 2007 to 2024.
- How do Brazil and Cambodia rank globally for previously treated cases tested for rr-/mdr-tb?
- Brazil ranks 128th and Cambodia ranks 128th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.